| http://www.w3.org/ns/prov#value | - King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products that complement the Company's focus in sp'/>/>Source: PRWebCopyright??2009 Vocus, Inc.All rights reserved0GOODPage: 1 2 3 4 5 6 Related medicine news :1.
|
